Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Onderzoeksoutput
- 8 resultaten
Zoekresultaten
-
2023
1860P Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Vanlaer, N., Dirven, I., Vounckx, M., Tijtgat, J., Verhaert, M., Aspeslagh, S., Decoster, L., Rogiers, A. & Neyns, B., okt 2023, In: Annals of Oncology. 34, 1 blz., 1860P.Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)+/CD141(BDCA-3)+ myeloid dendritic cells in solid tumors
Vounckx, M., Tijtgat, J., Dirven, I., Vandenbroucke, F., Raeymaeckers, S., Ilsen, B., Ben Mustapha, S., Van Loon, J., Stevens, L., Geeraerts, X., Van Riet, I., Dufait, I., Tuyaerts, S., Decoster, L., De Ridder, M. & Neyns, B., 2 nov 2023, In: Journal for immunotherapy of cancer. 11, 1, 1 blz., 694.Onderzoeksoutput: Meeting abstract (Journal)
Open AccessBestand8 Downloads (Pure) -
2022
790 Phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells plus ipilimumab and AS01B in combination with intravenously administered nivolumab
Tijtgat, J., Schwarze, J. K., Vander Mijnsbrugge, A-S., Raeymaeckers, S., Van Riet, I., Geeraerts, X., Stevens, L., Tuyaerts, S. & Neyns, B., 7 nov 2022, In: Journal for immunotherapy of cancer. 10, Suppl 2Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
A phase I clinical trial on intracranial administration of autologous myeloid dendritic cells (myDC) in combination with ipilimumab and nivolumab in patients with recurrent glioblastoma (rGB)
Schwarze, J. K., Geens, W., Tijtgat, J., Awada, G., Seynaeve, L., Vanbinst, A-M., Everaert, H., Michotte, A., Bruneau, M., Van Riet, I., Tuyaerts, S., Duerinck, J. & Neyns, B., 1 jun 2022, In: Journal of Clinical Oncology. 40, 16, 2033.Onderzoeksoutput: Meeting abstract (Journal)
Open AccessBestand4 Downloads (Pure) -
A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF INCREASING DOSES OF IPILIMUMAB PLUS FIXED DOSE NIVOLUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA (RGB)
Geens, W., Schwarze, J. K., Tijtgat, J., Lescrauwaet, L., Tuyaerts, S., Geeraerts, X., Stevens, L., Vanbinst, A-M., Everaert, H., Bruneau, M., Duerinck, J. & Neyns, B., nov 2022, In: Neuro-oncology. 24, blz. 62-62 1 blz.Onderzoeksoutput: Meeting abstract (Journal)
-
2021
Abstract 962MO. A phase I clinical trial on intratumoral injection of autologous CD1C (BDCA-1)+/CD141 (BDCA-3)+ myeloid dendritic cells (myDC) in combination with talimogene laherparepvec (T-VEC) in patients with advanced pretreated melanoma
Schwarze, J. K., Tijtgat, J., Awada, G., Cras, L., Dufait, I., Forsyth, R., Van Riet, I., Tuyaerts, S. & Neyns, B., 1 sep 2021, In: Annals of Oncology. 32, blz. S832-S833Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
A phase 2 clinical trial on trametinib and low-dose dabrafenib in advanced pretreated BRAF(V600)/NRAS(Q61R/K/L) wild-type melanoma (TraMel-WT): Interim efficacy and safety results.
Awada, G., Schwarze, J. K., Tijtgat, J., Fasolino, G., Everaert, H. & Neyns, B., 20 mei 2021, In: Journal of Clinical Oncology. 39, 15, 9529.Onderzoeksoutput: Meeting abstract (Journal)
Open Access -
2020
65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Schwarze, J. K., Bertels, C., Awada, G., Tijtgat, J., Tuyaerts, S., Cras, L., Vaeyens, F., Vanbinst, A-M., Everaert, H., Michotte, A., Caljon, B., Olsen, C., Janssen, T., Van Dooren, S., Forsyth, R., Duerinck, J. & Neyns, B., dec 2020, In: Annals of Oncology. 31, S7, blz. S1443-S1443Onderzoeksoutput: Meeting abstract (Journal)